Cargando…
Thalidomide Reduces Vascular Endothelial Growth Factor Immunostaining in Canine Splenic Hemangiosarcoma
Hemangiosarcomas (HSA) are common neoplasms of dogs that often metastasize and are typically fatal. Recently it was demonstrated that thalidomide extends the survival time of dogs with HSA, potentially due to thalidomide-induced inhibition of vascular endothelial growth factor (VEGF) production by t...
Autores principales: | Bray, Jonathan P., Munday, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355933/ https://www.ncbi.nlm.nih.gov/pubmed/32443710 http://dx.doi.org/10.3390/vetsci7020067 |
Ejemplares similares
-
A canine case of splenic hemangiosarcoma complicated with infectious splenic abscess
por: Oyamada, Tomohiro, et al.
Publicado: (2022) -
Immunostaining for VEGF and Decorin Predicts Poor Survival and Recurrence in Canine Soft Tissue Sarcoma
por: Bray, Jonathan P., et al.
Publicado: (2023) -
Hyperferritinemia in Dogs with Splenic Hemangiosarcoma
por: CHIKAZAWA, Seishiro, et al.
Publicado: (2013) -
Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma
por: Gardner, Heather L., et al.
Publicado: (2015) -
Histopathological Grading, Clinical Staging and CD 31 Expression of Canine Splenic Hemangiosarcoma
por: Chu, Ka-To, et al.
Publicado: (2023)